Abstract
The immunosuppressive action of hyperbaric oxygen (HBOX) has been proved by experimental studies in allergic encephalomyelitis [1] and other pathologies. Since 1970, clinical studies, most of them uncontrolled and nonblind, have been set up to evaluate the possible efficacy of HBOX in patients with multiple sclerosis (MS). The results have been controversial: some trials reported a positive action of HBOX [2] while others have not shown any clinical improvement [3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Warren J, Sacksteder MR, Thuning CA (1978) Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol 121:315–320
Fischer BH, Marks M, Reich F (1983) Hyperbaric oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Engl J Med 308:181–186
Barnes MP, Bates D, Cartlidge NEF, French JM, Shaw DA (1985) Hyperbaric oxygen and multiple sclerosis: short-term results of a placebo-controlled, double-blind trial. Lancet i: 297–300
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnosis criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Kurtzke JF (1984) The evaluation of disability in mutliple sclerosis: In: Scheinberg L, Raine CS (eds) M.S.: experimental and clinical aspects. Ann NY Acad Sci 436
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Barbieri, S., Pirovano, C., Cislaghi, G., Albonico, G., Oriani, G., Mariani, C. (1988). Long-Term Hyperbaric Oxygen in Chronic Progressive Multiple Sclerosis: A Placebo-Controlled Double-Blind Randomized Study with Evoked Potential Evaluation. In: Cazzullo, C.L., Caputo, D., Ghezzi, A., Zaffaroni, M. (eds) Virology and Immunology in Multiple Sclerosis: Rationale for Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73032-0_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-73032-0_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73034-4
Online ISBN: 978-3-642-73032-0
eBook Packages: Springer Book Archive